In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS's flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. Without Congressional action, more…
In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to reform payment to clinical laboratories under the Clinical Laboratory Fee Schedule (CLFS). CMS's flawed implementation led to rates that fail to reflect private payer rates as intended, years of payment cuts, and a lack of recognition of rising inflation. Without Congressional action, more cuts will begin on January 1, 2025. ACLA urges Congress to enact long-term PAMA reform to protect access to quality laboratory diagnostics and services.
-
ACLA Applauds Congressional Action to Delay Medicare Cuts, Urges Long-Term Reform
Washington, D.C.— The American Clinical Laboratory Association (ACLA) today commended Congress for including much-needed relief from looming Medicare payment cuts to clinical laboratory services in ... Read More -
ACLA Launches 2024 ‘Stop Lab Cuts’ Campaign Urging Congress to Protect Access to Laboratory Services
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today launched its 2024 Stop Lab Cuts campaign, including a series of digital advertisements urging Congress to ... Read More -
ACLA Statement on One-Year Delay to Clinical Laboratory Payment Cuts Being Included in Congressional Spending Package
Washington, D.C.– The American Clinical Laboratory Association (ACLA) commends the inclusion of critically needed relief from looming Medicare payment cuts to clinical laboratory services in ... Read More -
ACLA Statement on House Energy and Commerce Subcommittee Hearing on Medicare Legislation
Washington, D.C. – The American Clinical Laboratory Association’s (ACLA) President, Susan Van Meter, issued the following statement after the House Energy and Commerce Committee’s Health ... Read More -
Letter from Leading Patient Advocacy Organizations on Passing the Saving Access to Laboratory Services Act
-
Letter from Leading Provider Organizations on Passing the Saving Access to Laboratory Services Act
-
ACLA and 33 Provider Organizations Urge Congress to Protect Americans’ Access to Essential Laboratory Tests
Washington, D.C. – The American Clinical Laboratory Association has joined with more than 30 health care provider organizations to urge House and Senate leadership to protect ... Read More -
ACLA Applauds Introduction of Bipartisan Bill to Protect Seniors’ Access to Critical Diagnostic Tests
Association Relaunches ‘Stop Lab Cuts’ Campaign Washington, D.C. – The American Clinical Laboratory Association (ACLA) today welcomed the bipartisan and bicameral introduction of the Saving ... Read More -
ACLA Commends the 2023 Omnibus Appropriations Bill
The 2023 Omnibus provides critical relief for labs and patients Washington, D.C. – The American Clinical Laboratory Association (ACLA) commends inclusion in the 2023 Omnibus Appropriations Bill ... Read More -
New Analysis Shows Value of Clinical Laboratories to the U.S. Economy
Repeated Medicare Cuts Could Weaken Laboratory Infrastructure, Industry Warns Washington, D.C. – The American Clinical Laboratory Association (ACLA), representing the nation’s leading clinical laboratories, today ... Read More
